Abogen is a China-based clinical-stage biotechnology company advancing mRNA-based therapeutics for the treatment of cancer and infectious diseases, including COVID-19.
Member count: 11-50
Founded date: 2019
Investors 6
| Date | Name | Website |
| - | Octagon Ca... | octagoninv... |
| 23.02.2022 | 5Y Capital | 5ycap.com |
| - | Qiming Ven... | qimingvent... |
| - | YF Capital | yfc.cn |
| 24.08.2021 | Qiming Ven... | qimingvc.c... |
| 13.10.2022 | IMO Ventur... | imo.vc/ |
Mentions in press and media 2
| Date | Title | Description | Category | Author | Source |
| 18.04.2022 | Biotech's ... | After a bustling, record-setti... | - | - | fiercebiot... |
| 30.11.2021 | China’s Ab... | Chinese mRNA vaccine developer... | - | Liya Su | dealstreet... |